drugset / Trial / NCT00347022

A Clinical Study of Xenetix 300 in Multislice Computed Tomography (CT) Pediatric Indications

NCT00347022

Phase 4 Completed 145 enrolled Guerbet
RandomizedParallel-groupTriple-blindDiagnostic

Summary

This is a clinical study of Xenetix 300 in Multislice Computed Tomography (MSCT) in pediatric indications.

Timeline

Start
2006-05
Primary completion
2009-04
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Iobitridol Diagnostic / imaging agent 300 mg/ml
Comparator Iodixanol Diagnostic / imaging agent 270 mg/ml

Indications

No indication recorded.